Dashboard
Manage Tickers

EXC EXELON CORP

Nasdaq exeloncorp.com


$ 47.79 $ 0.42 (0.89 %)    

Friday, 17-Oct-2025 15:59:59 EDT
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 604.92 $ 3.94 (0.66 %)
DIA $ 461.73 $ 2.22 (0.48 %)
SPY $ 665.28 $ 3.75 (0.57 %)
TLT $ 91.09 $ -0.14 (-0.15 %)
GLD $ 391.28 $ -7.46 (-1.88 %)
$ 47.78
$ 47.58
$ 46.75 x 2
$ 48.10 x 50
$ 47.36 - $ 48.07
$ 34.98 - $ 48.07
7,553,644
na
62.88B
$ 0.50
$ 23.70
TBD
na
na ($ 0.03)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 07-31-2025 06-30-2025 10-Q
2 05-01-2025 03-31-2025 10-Q
3 02-12-2025 12-31-2024 10-K
4 10-30-2024 09-30-2024 10-Q
5 08-01-2024 06-30-2024 10-Q
6 05-02-2024 03-31-2024 10-Q
7 02-21-2024 12-31-2023 10-K
8 11-02-2023 09-30-2023 10-Q
9 08-02-2023 06-30-2023 10-Q
10 05-03-2023 03-31-2023 10-Q
11 02-14-2023 12-31-2022 10-K
12 11-03-2022 09-30-2022 10-Q
13 08-03-2022 06-30-2022 10-Q
14 05-09-2022 03-31-2022 10-Q
15 02-25-2022 12-31-2021 10-K
16 11-03-2021 09-30-2021 10-Q
17 08-04-2021 06-30-2021 10-Q
18 05-05-2021 03-31-2021 10-Q
19 02-24-2021 12-31-2020 10-K
20 11-03-2020 09-30-2020 10-Q
21 08-04-2020 06-30-2020 10-Q
22 05-08-2020 03-31-2020 10-Q
23 02-11-2020 12-31-2019 10-K
24 10-31-2019 09-30-2019 10-Q
25 08-01-2019 06-30-2019 10-Q
26 05-02-2019 03-31-2019 10-Q
27 02-08-2019 12-31-2018 10-K
28 11-01-2018 09-30-2018 10-Q
29 08-02-2018 06-30-2018 10-Q
30 05-02-2018 03-31-2018 10-Q
31 02-09-2018 12-31-2017 10-K
32 11-02-2017 09-30-2017 10-Q
33 08-02-2017 06-30-2017 10-Q
34 05-03-2017 03-31-2017 10-Q
35 02-13-2017 12-31-2016 10-K
36 10-26-2016 09-30-2016 10-Q
37 08-09-2016 06-30-2016 10-Q
38 05-10-2016 03-31-2016 10-Q
39 02-10-2016 12-31-2015 10-K
40 10-30-2015 09-30-2015 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

price-over-earnings-overview-exelon
Price Over Earnings Overview: Exelon
10/17/2025 21:00:32

keybanc-maintains-underweight-on-exelon-raises-price-target-to-42
Keybanc Maintains Underweight on Exelon, R...
10/15/2025 15:31:55

Keybanc analyst Sophie Karp maintains Exelon (NASDAQ:EXC) with a Underweight and raises the price target from $37 to $42.

barclays-maintains-overweight-on-exelon-raises-price-target-to-52
Barclays Maintains Overweight on Exelon, R...
10/14/2025 15:03:11

Barclays analyst Nicholas Campanella maintains Exelon (NASDAQ:EXC) with a Overweight and raises the price target from $48 to...

ubs-maintains-neutral-on-exelon-raises-price-target-to-50
UBS Maintains Neutral on Exelon, Raises Pr...
10/10/2025 14:40:53

UBS analyst Daniel Ford maintains Exelon (NASDAQ:EXC) with a Neutral and raises the price target from $48 to $50.

evercore-isi-group-initiates-coverage-on-exelon-with-outperform-rating-announces-price-target-of-57
Evercore ISI Group Initiates Coverage On E...
10/07/2025 13:06:38

Evercore ISI Group analyst Nicholas Amicucci initiates coverage on Exelon (NASDAQ:EXC) with a Outperform rating and announce...

morgan-stanley-maintains-equal-weight-on-exelon-lowers-price-target-to-49
Morgan Stanley Maintains Equal-Weight on E...
09/25/2025 17:40:19

Morgan Stanley analyst David Arcaro maintains Exelon (NASDAQ: EXC) with a Equal-Weight and lowers the price target from $50 ...

price-over-earnings-overview-exelon
Price Over Earnings Overview: Exelon
09/05/2025 22:00:23

marjorie-taylor-greene-hits-homerun-again-buys-alphabet-stock-5-days-before-favorable-antitrust-ruling-here-are-some-other-new-trades
Marjorie Taylor Greene Hits Homerun Again,...
09/03/2025 06:16:51

Rep. Marjorie Taylor Greene buys Google stock just days before a key antitrust ruling. See her latest trades and portfolio perf...

whats-driving-the-market-sentiment-around-exelon
What's Driving the Market Sentiment Around...
09/02/2025 14:00:38

recent-filing-shows-that-rep-marjorie-taylor-greene-bought-over-54k-worth-of-exelon-stock
Recent Filing Shows That Rep. Marjorie Tay...
09/01/2025 15:00:13

meta-microsoft-power-wall-street-to-new-records-despite-inflation-jump-whats-moving-markets-thursday
Meta, Microsoft Power Wall Street To New R...
07/31/2025 17:21:14

A post-earnings surge in Meta Platforms Inc. (NASDAQ:META) and Microsoft Corp.

exelon-affirms-fy2025-adj-eps-guidance-of-264-274-vs-269-est
Exelon Affirms FY2025 Adj EPS Guidance of ...
07/31/2025 10:51:32

Exelon (NASDAQ:EXC) affirms FY2025 Adj EPS guidance from $2.64-$2.74 to $2.64-$2.74 vs $2.69 analyst estimate..

exelon-q2-adj-eps-039-misses-044-estimate-sales-5427b-miss-5572b-estimate
Exelon Q2 Adj. EPS $0.39 Misses $0.44 Esti...
07/31/2025 10:51:13

Exelon (NASDAQ:EXC) reported quarterly earnings of $0.39 per share which missed the analyst consensus estimate of $0.44 by 11.9...

Core News & Articles
Earnings Scheduled For July 31, 2025
07/31/2025 08:32:50

examining-the-future-exelons-earnings-outlook
Examining the Future: Exelon's Earnings Ou...
07/30/2025 15:02:42

comed-ceo-seeks-rules-to-prevent-ai-from-boosting-energy-bills--bloomberg
'ComEd CEO Seeks Rules To Prevent AI from ...
07/25/2025 11:56:18

https://www.bloomberg.com/news/articles/2025-07-25/comed-ceo-seeks-rules-to-prevent-ai-from-boosting-energy-bills?srnd=homepage...

whats-driving-the-market-sentiment-around-exelon
What's Driving the Market Sentiment Around...
07/18/2025 18:00:27

keybanc-maintains-underweight-on-exelon-lowers-price-target-to-37
Keybanc Maintains Underweight on Exelon, L...
07/16/2025 15:05:11

Keybanc analyst Jackson Ader maintains Exelon (NASDAQ:EXC) with a Underweight and lowers the price target from $39 to $37.

ubs-maintains-neutral-on-exelon-raises-price-target-to-48
UBS Maintains Neutral on Exelon, Raises Pr...
07/11/2025 19:13:52

UBS analyst Daniel Ford maintains Exelon (NASDAQ:EXC) with a Neutral and raises the price target from $47 to $48.

looking-into-exelons-recent-short-interest
Looking Into Exelon's Recent Short Interest
07/01/2025 14:00:29

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION